Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 64,649 | 49,988 | 27,132 | 10,033 | 3,792 |
| Cost of Goods | 25,123 | 26,928 | 14,030 | 11,734 | 5,929 |
| Gross Profit | 39,526 | 23,060 | 13,102 | -1,701 | -2,137 |
| Operating Expenses | 50,064 | 67,484 | 69,673 | 74,857 | 25,370 |
| Operating Income | -10,415 | -43,496 | -56,541 | -75,824 | -26,578 |
| Interest Expense | 8,009 | 8,974 | 10,085 | 6,937 | 3,721 |
| Other Income | 1,533 | 795 | 854 | 10 | -482 |
| Pre-tax Income | -16,891 | -51,675 | -65,772 | -82,751 | -30,781 |
| Income Tax | 11 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -16,902 | -51,675 | -65,772 | -82,751 | -30,781 |
| Net Income | $-16,902 | $-51,675 | $-65,772 | $-82,751 | $-30,781 |
| EPS Basic Total Ops | -0.34 | -1.60 | -2.66 | -5.16 | -4.38 |
| EPS Basic Continuous Ops | -0.34 | -1.60 | -2.66 | -5.16 | -4.06 |
| EPS Diluted Total Ops | -0.34 | -1.60 | -2.66 | -5.16 | -4.38 |
| EPS Diluted Continuous Ops | -0.34 | -1.60 | -2.66 | -5.16 | -4.06 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -1.60 | -2.68 | -5.19 | -4.38 |
| EBITDA(a) | $-4,845 | $-39,179 | $-52,328 | $-72,314 | $-22,760 |